Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation

par Tian Tian, Min Yu, Juan Li, Maoqiong Jiang, Daiyuan Ma, Shubin Tang, Zhiyu Lin, Lin Chen, Youling Gong, Jiang Zhu, Qiang Zhou, Meijuan Huang, You Lu
Publié 2021

Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MB

par Alexander Sergeevich Ametov, Lyudmila Nikolaevna Bogdanova
Publié 2009

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension

par Nicholas P Bell, José L Ramos, Robert M Feldman
Publié 2010

Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

par Pol S, Corouge M, Vallet-Pichard A
Publié 2016

Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting

par Hiroyuki Goto, Yoshimoto Okada, Seimi Watanabe, Kanako Danno, Shinya Yamamoto, Ryohei Ishiura, Yuichi Nakayama, Kohei Mitsui, Ayaka Ueki, Yasuo Nakai, Mitsunaga Narushima, Keiichi Yamanaka
Publié 2021

The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy

par Xin Xie, Jingwen Lv, Wei Zhu, Chao Tian, Jingfeng Li, Jiajia Liu, Hua Zhou, Chunyang Sun, Zongfeng Hu, Xiaopeng Li
Publié 2022

CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION

par T. A. Dronova, D. V. Polyakov
Publié 2014

Gambogic Acid as a Candidate for Cancer Therapy: A Review

par Liu Y, Chen Y, Lin L, Li H
Publié 2020

Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer

par He W, Xiao W, Zhang X, Sun Y, Chen Y, Chen Q, Fang X, Du S, Sha X
Publié 2020

Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms

par Mohammad Tobeiha, Ali Rajabi, Arash Raisi, Mahshad Mohajeri, Soheil Mohammadi Yazdi, Amirhossein Davoodvandi, Fatemeh Aslanbeigi, MohamadSadegh Vaziri, Michael R. Hamblin, Hamed Mirzaei
Publié 2021

Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy

par Du X, Zhang T, Ma G, Gu X, Wang G, Li J
Publié 2019

Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy

par Xie JJ, Fan ZX, Li Y, Zhang YY, Yu F, Su GH, Xie LY, Hou ZQ
Publié 2018

Impact on facial rejuvenation with dermatological preparations

par Patrick J Bowler
Publié 2009

Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects

par Jiang H, Li ZP, Tian GX, Pan RY, Xu CM, Zhang B, Wu JL
Publié 2019

Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice

par Yifang Li, Amlan Chakraborty, Brad R.S. Broughton, Dorota Ferens, Robert E. Widdop, Sharon D. Ricardo, Chrishan S. Samuel
Publié 2021

Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer

par Zhang B, Song YM, Wang TQ, Yang SM, Zhang J, Liu YJ, Zhang N, Garg S
Publié 2017

Combined administration of PTX and S-HM-3 in TPGS/Solutol micelle system for oncotarget therapy

par Li W, Xue J, Xu H
Publié 2019

Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel

par Huang Z, Xiao H, Lu X, Yan W, Ji Z
Publié 2018

IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer

par Claudia Tulotta, Diane V. Lefley, Charlotte K. Moore, Ana E. Amariutei, Amy R. Spicer-Hadlington, Lewis A. Quayle, Russell O. Hughes, Khawla Ahmed, Victoria Cookson, Catherine A. Evans, Jayakumar Vadakekolathu, Paul Heath, Sheila Francis, Emmanuel Pinteaux, A. Graham Pockley, Penelope D. Ottewell
Publié 2021

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies

par Marina V. Shestakova, Ekaterina A. Yudovich
Publié 2017